A Case of Recurrent Cervical Cancer Treated with Cadonilimab Monotherapy and Combination Chemotherapy
SHI Rui
FENG Shu-xian
MA Wei
ZHANG Zong-cui
Abstract：The incidence rate of cervical cancer is the highest among gynecological malignancies.At present,surgery is still an effective treatment for early-stage cervical cancer,but cervical cancer has a high recurrence rate and distant metastasis,poor prognosis in advanced stages,and limited treatment options.This article focuses on a case with recurrence of cervical cancer despite radical hysterectomy and combined chemotherapy and radiotherapy,who developed vesicovaginal fistula and rectovaginal fistula with severe infection,and achieved a survival benefit by treatment with cadonilimab monotherapy and combination chemotherapy.It aims to provide new ideas for the treatment of recurrent cervical cancer.
Keywords：Uterine cervical neoplasmsImmunotherapyCadonilimabRecurrenceDrug therapycombination
Publication Date：2023-12-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 665-667 )